Thermo Fisher Scientific Inc.
Mega Cap · Healthcare · Diagnostics & Research
$588.03−$7.86 (-1.32%)
Thermo Fisher Scientific Inc.
Mega Cap · Healthcare · Diagnostics & Research
$588.03−$7.86 (-1.32%)
Stock analysis
Get the AI take on TMO
Track it to unlock the price chart, verdict and what could change it.
- ✓Live price chart
- ✓A clear accumulate, trim or avoid call
Free to track. No card required.
Stock Fundamentals & Key Indicators
52-week range
Low$405.15
High$643.99
Today $588.03
RSI (14)
62.7Neutral
03070100
Overall score
61/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
- ✓5 years of revenue, profit and cash flow
- ✓Valuation and balance-sheet checks
- ✓Business and geographic mix
- ✓Analyst targets and recommendation trend
Free for 3 days, then $9/mo. Cancel anytime.
Analyst Rating and Sentiment
Analyst price targets
Lowest
$520
Current price
$588.03
Median target
$642.5
Highest
$750
LowHigh
Operating Record
Revenue
What's working
- Current ratio: What's on hand comfortably covers the bills due over the next year.
What to watch
- Debt exceeds cash by $38.5B, increasing balance-sheet pressure, a warning sign.
What the market charges
Forward P/E
Middle ground · In line with avg
22.41x
Price / sales
Reasonable · Priced reasonably against its revenue
4.69x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
29.72x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
21.81x
How efficiently it compounds
ROIC
Reasonable · A middling return on the capital it puts to work
8.8%
ROE
Middle ground · Mixed
13.5%
Debt / equity
Middle ground · Mixed
0.81x
Current ratio
Strong · Comfortable room to cover bills due within a year
1.55x
Peer Comparison
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $217.52B | 31.6 | +7.2% | 61 |
 | $11.53B | 22.0 | +19.7% | 78 |
 | $4.60B | 13.9 | +13.5% | 77 |
 | $33.87B | 35.4 | +15.5% | 77 |
 | $1.11T | 40.1 | +49.6% | 76 |